{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:02:09Z","timestamp":1794434529463,"version":"4.9.1"},"reference-count":143,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["2018-123\/01KU1904"],"award-info":[{"award-number":["2018-123\/01KU1904"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["109005"],"award-info":[{"award-number":["109005"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 2017.03"],"award-info":[{"award-number":["DKS 2017.03"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.beha.2020.101197","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T12:01:40Z","timestamp":1596024100000},"page":"101197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes"],"prefix":"10.1016","volume":"33","author":[{"given":"Sushree S.","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia J.","family":"Kozyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2020.101197_bib1","series-title":"Historische F\u00e4lle aus der Medizin: erstbeschreibungen von der Ahornsiruperkrankung bis zum Pfeifferschen Dr\u00fcsenfieber","first-page":"249","article-title":"Die pernizi\u00f6se Fanconi-An\u00e4mie, 1927","author":"B\u00f6hles","year":"2020"},{"key":"10.1016\/j.beha.2020.101197_bib2","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.beha.2020.101197_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","article-title":"Mutations in SBDS are associated with Shwachman-Diamond syndrome","volume":"33","author":"Boocock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expet Rev Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","article-title":"The landscape of somatic mutations in Down syndrome-related myeloid disorders","volume":"45","author":"Yoshida","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ejhg.2017.65","article-title":"Genotype and phenotype spectrum of NRAS germline variants","volume":"25","author":"Altmuller","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cge.12517","article-title":"Fanconi anaemia: genetics, molecular biology, and cancer - implications for clinical management in children and adults","volume":"88","author":"Schneider","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.beha.2020.101197_bib10","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.1803275115","article-title":"Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants","volume":"115","author":"Tummala","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2020.101197_bib11","first-page":"429","article-title":"Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy","volume":"96","author":"Freedman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/blood-2006-02-004275","article-title":"Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey","volume":"109","author":"Germeshausen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.beha.2020.101197_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmg.2016.01.003","article-title":"Acute lymphoblastic leukemia in the context of RASopathies","volume":"59","author":"Cave","year":"2016","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.beha.2020.101197_bib15","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib16","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood-2019-01-896233","article-title":"ERCC6L2 defines a novel entity within inherited acute myeloid leukemia","volume":"133","author":"Douglas","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib17","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/nyas.13097","article-title":"Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia","volume":"1370","author":"Klimiankou","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beha.2020.101197_bib19","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2009-07-232512","article-title":"RAS and CSF3R mutations in severe congenital neutropenia","volume":"114","author":"Germeshausen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib20","first-page":"139","article-title":"RUNX1 mutations in the leukemic progression of severe congenital neutropenia","volume":"43","author":"Olofsen","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.beha.2020.101197_bib21","article-title":"Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"2020","author":"Kennedy","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.beha.2020.101197_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40291-018-0368-2","article-title":"Shwachman diamond syndrome: molecular mechanisms and current perspectives","volume":"23","author":"Bezzerri","year":"2019","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.beha.2020.101197_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000484749","article-title":"Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance","volume":"5","author":"Lo Ten Foe","year":"1997","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000069805","article-title":"Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction","volume":"98","author":"Gross","year":"2002","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.beha.2020.101197_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mgg3.350","article-title":"Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype","volume":"6","author":"Asur","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.beha.2020.101197_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ajhg.2012.01.004","article-title":"Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita","volume":"90","author":"Jongmans","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib29","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2020.101197_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijlh.12999","article-title":"Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia","volume":"41","author":"Galera","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Canc Cell"},{"key":"10.1016\/j.beha.2020.101197_bib35","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41375-019-0675-6","article-title":"Familial myeloid malignancies with germline TET2 mutation","volume":"34","author":"Duployez","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2020.101197_bib37","first-page":"613","article-title":"SAMD9 and SAMD9L germline disorders in patients Enrolled in studies of the European working group of MDS in childhood (EWOG-MDS): prevalence, outcome, phenotype and functional characterisation","volume":"132","author":"Sahoo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12185-017-2285-2","article-title":"Heterogeneity of GATA2-related myeloid neoplasms","volume":"106","author":"Hirabayashi","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.beha.2020.101197_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","article-title":"Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis","volume":"93","author":"Persons","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib42","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1172\/JCI61619","article-title":"Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning","volume":"122","author":"Lim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2020.101197_bib43","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20130751","article-title":"Gata2 is required for HSC generation and survival","volume":"210","author":"de Pater","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2020.101197_bib44","first-page":"291","article-title":"Gata2 as a crucial regulator of stem cells in adult hematopoiesis and acute myeloid leukemia","volume":"13","author":"Menendez-Gonzalez","year":"2019","journal-title":"J Stem Cell Res Rev Rep"},{"key":"10.1016\/j.beha.2020.101197_bib45","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib46","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","article-title":"High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","volume":"121","author":"Pasquet","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3324\/haematol.2011.054361","article-title":"Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival","volume":"97","author":"Bodor","year":"2012","journal-title":"Haematologica-the Hematology Journal"},{"key":"10.1016\/j.beha.2020.101197_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2141.2012.09136.x","article-title":"Marked genetic heterogeneity in familial myelodysplasia\/acute myeloid leukaemia","volume":"158","author":"Holme","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib56","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib57","first-page":"467","article-title":"GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome","volume":"22","author":"Brambila-Tapia","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.beha.2020.101197_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2018.11.013","article-title":"MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations","volume":"76","author":"McReynolds","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2020.101197_bib59","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41375-018-0134-9","article-title":"GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS\/AML","volume":"32(11)","author":"Al Seraihi","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/10428194.2018.1516039","article-title":"Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation","volume":"60","author":"Kim","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2020.101197_bib61","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Novakova","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3324\/haematol.2014.113456","article-title":"Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity","volume":"100","author":"Zhang","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125(1)","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib65","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.5MA0815-388R","article-title":"Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations","volume":"99","author":"Maciejewski-Duval","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.beha.2020.101197_bib66","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.imlet.2013.11.018","article-title":"Primary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia","volume":"161","author":"Dotta","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.beha.2020.101197_bib67","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2011.041152","article-title":"Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications","volume":"96","author":"Calvo","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib68","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2020.101197_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2020.101197_bib70","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jhep.2016.01.017","article-title":"Single-gene association between GATA-2 and autoimmune hepatitis: a novel genetic insight highlighting immunologic pathways to disease","volume":"64","author":"Webb","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.beha.2020.101197_bib71","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/j.clml.2019.05.015","article-title":"Fifty Shades of GATA2 mutation: a case of plasmablastic lymphoma, nontuberculous mycobacterial infection, and myelodysplastic syndrome","volume":"19","author":"Fakhri","year":"2019","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib72","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib73","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/leu.2015.40","article-title":"Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome\/acute myeloid leukemia with concurrent thrombocytopenia","volume":"29","author":"Hahn","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib74","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.4049\/jimmunol.1401868","article-title":"GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation","volume":"194","author":"Cortes-Lavaud","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2020.101197_bib75","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/leu.2017.196","article-title":"Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes","volume":"32","author":"Chong","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10875-018-0512-0","article-title":"Lethal influenza in two related adults with inherited GATA2 deficiency","volume":"38(4)","author":"Sologuren","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.beha.2020.101197_bib77","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2018-03-837336","article-title":"A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing","volume":"132","author":"Wehr","year":"2018","journal-title":"Blood"},{"issue":"Online ahead of print","key":"10.1016\/j.beha.2020.101197_bib79","article-title":"Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome","volume":"Apr 14","author":"Cavalcante de Andrade Silva","year":"2020","journal-title":"Leukemia"},{"issue":"Online ahead of print","key":"10.1016\/j.beha.2020.101197_bib81","article-title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","volume":"Jun 18","author":"Kozyra","year":"2020","journal-title":"Leukemia"},{"issue":"Online ahead of print","key":"10.1016\/j.beha.2020.101197_bib82","article-title":"A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability","volume":"Jun 3","author":"Fox","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41408-018-0123-2","article-title":"GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia","volume":"8","author":"Tien","year":"2018","journal-title":"Blood Canc J"},{"key":"10.1016\/j.beha.2020.101197_bib84","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.0711824105","article-title":"Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2020.101197_bib85","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2012-01-403220","article-title":"GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia","volume":"120","author":"Greif","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib86","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2011-12-397083","article-title":"High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia","volume":"120","author":"Luesink","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib87","first-page":"21","article-title":"GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation","volume":"2","author":"Niimi","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2020.101197_bib88","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/leu.2012.174","article-title":"GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib89","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.12317","article-title":"GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations","volume":"161","author":"Green","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjh.12559","article-title":"Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia","volume":"164","author":"Shiba","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00277-014-2208-8","article-title":"GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution","volume":"94(2)","author":"Hou","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib92","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2016.185","article-title":"Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group","volume":"30","author":"Theis","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/leu.2016.162","article-title":"Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia","volume":"31","author":"Ping","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib94","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/bloodadvances.2017012617","article-title":"Can somatic GATA2 mutation mimic germ line GATA2 mutation?","volume":"2","author":"Sekhar","year":"2018","journal-title":"Adv Blood Grouping"},{"key":"10.1016\/j.beha.2020.101197_bib95","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1080\/10428194.2018.1551535","article-title":"Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype","volume":"60","author":"Alfayez","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"10.1016\/j.beha.2020.101197_bib96","article-title":"Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency","volume":"126","author":"Loyola","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib97","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.3324\/haematol.2015.127092","article-title":"GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies","volume":"100","author":"Wang","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/leu.2016.256","article-title":"Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency","volume":"31","author":"Ding","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib99","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/bloodadvances.2016002311","article-title":"Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency","volume":"1","author":"Fisher","year":"2017","journal-title":"Adv Blood Grouping"},{"key":"10.1016\/j.beha.2020.101197_bib100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/leu.2016.342","article-title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","volume":"31","author":"Pastor","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib101","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00277-014-2090-4","article-title":"Identification of acquired mutations by whole-genome sequencing in GATA-2 deficiency evolving into myelodysplasia and acute leukemia","volume":"93","author":"Fujiwara","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib102","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"557","article-title":"Pediatric MDS including refractory cytopenia and juvenile myelomonocytic leukemia","author":"Niemeyer","year":"2019"},{"key":"10.1016\/j.beha.2020.101197_bib103","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib104","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/TP.0000000000000520","article-title":"Allogeneic hematopoietic cell transplantation for GATA2 deficiency in a patient with disseminated human Papillomavirus disease","volume":"98","author":"Maeurer","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2020.101197_bib105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2017-10-811489","article-title":"In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction","volume":"131","author":"Tholouli","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib106","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00277-018-3388-4","article-title":"Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature","volume":"97","author":"Simonis","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2020.101197_bib107","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.16247","article-title":"GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner","volume":"188","author":"Bogaert","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib108","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20(12)","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2020.101197_bib109","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/JVI.02243-10","article-title":"M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells","volume":"85","author":"Liu","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.beha.2020.101197_bib110","doi-asserted-by":"crossref","first-page":"14858","DOI":"10.1073\/pnas.1515354112","article-title":"Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins","volume":"112","author":"Meng","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2020.101197_bib111","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.virol.2017.01.004","article-title":"An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function","volume":"503","author":"Nounamo","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.beha.2020.101197_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006884","article-title":"A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection","volume":"14","author":"Meng","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.beha.2020.101197_bib113","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2009.04.004","article-title":"Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome","volume":"383","author":"Asou","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.beha.2020.101197_bib114","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3892\/ol.2015.4000","article-title":"miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9","volume":"11","author":"Wu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.beha.2020.101197_bib115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib116","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.jid.5701203","article-title":"Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein","volume":"128","author":"Chefetz","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.beha.2020.101197_bib117","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beha.2020.101197_bib118","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2020.101197_bib119","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127(5)","author":"Buonocore","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2020.101197_bib120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Canc Cell"},{"key":"10.1016\/j.beha.2020.101197_bib121","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms","volume":"129(16)","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib122","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101197_bib123","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib124","first-page":"3","article-title":"Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.beha.2020.101197_bib125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101197_bib126","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130(4)","author":"de Jesus","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2020.101197_bib128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/bloodadvances.2017012682","article-title":"Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype","volume":"2","author":"Sarthy","year":"2018","journal-title":"Adv Blood Grouping"},{"key":"10.1016\/j.beha.2020.101197_bib129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ajmg.a.38557","article-title":"A novel SAMD9 mutation causing MIRAGE syndrome: an expansion and review of phenotype, dysmorphology, and natural history","volume":"176","author":"Jeffries","year":"2018","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beha.2020.101197_bib130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12881-018-0546-4","article-title":"A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing","volume":"19","author":"Kim","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beha.2020.101197_bib131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmedgenet-2017-105020","article-title":"Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations","volume":"55","author":"Shima","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.beha.2020.101197_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206184","article-title":"MIRAGE syndrome is a rare cause of 46,XY DSD born SGA without adrenal insufficiency","volume":"13","author":"Shima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2020.101197_bib133","first-page":"206","article-title":"A rare Etiology of 46, XY disorder of Sex development and adrenal insufficiency: a case of MIRAGE syndrome caused by mutations in SAMD9 gene","volume":"12(2)","author":"Mengen","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.beha.2020.101197_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27726","article-title":"A novel SAMD9 variant identified in patient with MIRAGE syndrome: further defining syndromic phenotype and review of previous cases","volume":"66","author":"Perisa","year":"2019","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.beha.2020.101197_bib135","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3389\/fimmu.2019.02194","article-title":"Novel SAMD9 mutation in a patient with immunodeficiency, neutropenia, impaired anti-CMV response, and severe gastrointestinal involvement","volume":"10","author":"Formankova","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.beha.2020.101197_bib136","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12887-019-1733-y","article-title":"Mutations in both SAMD9 and SLC19A2 genes caused complex phenotypes characterized by recurrent infection, dysphagia and profound deafness - a case report for dual diagnosis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.beha.2020.101197_bib137","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fendo.2019.00625","article-title":"Reversion SAMD9 Mutations Modifying Phenotypic Expression of MIRAGE Syndrome and Allowing Inheritance in a Usually de novo Disorder","volume":"10","author":"Roucher-Boulez","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beha.2020.101197_bib138","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41439-020-0091-5","article-title":"MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene","volume":"7","author":"Onuma","year":"2020","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.beha.2020.101197_bib139","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jnen\/nlaa009","article-title":"The neuropathology of MIRAGE syndrome","volume":"79","author":"Viaene","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.beha.2020.101197_bib140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12883-019-1319-1","article-title":"Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report","volume":"19","author":"Thunstrom","year":"2019","journal-title":"BMC Neurol"},{"key":"10.1016\/j.beha.2020.101197_bib141","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.3324\/haematol.2018.207316","article-title":"A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia","volume":"104","author":"Cheah","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101197_bib142","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101197_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27589","article-title":"Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation","volume":"66","author":"Csillag","year":"2019","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.beha.2020.101197_bib144","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/bjh.16322","article-title":"In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation","volume":"188","author":"Hockings","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2020.101197_bib145","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.bbmt.2019.07.007","article-title":"Outcomes of hematopoietic cell transplantation in patients with germline SAMD9\/SAMD9L mutations","volume":"25","author":"Ahmed","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2020.101197_bib146","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-17-0027","article-title":"Genetic defects in pediatric-onset adrenal insufficiency in Japan","volume":"177","author":"Amano","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beha.2020.101197_bib147","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2017.05.001","article-title":"Introduction: Genetic syndromes predisposing to myeloid neoplasia","volume":"54(2)","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol."}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169262030058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169262030058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:05:46Z","timestamp":1761498346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169262030058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":143,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S152169262030058X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2020.101197","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2020.101197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101197"}}